PARADIGM BIOPHARMACEUTICALS LIMITED has not announced any current capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
22 October 2018
15 April 2019
Paradigm Biopharmaceuticals Limited (PAR) is an Australian biopharmaceutical company focused on repurposing the drug 'pentosan polysulphate sodium' (PPS) for the treatment of bone marrow edema. Paradigm is targeting addressable markets with the aim to use the shortened development pathway utilising repurposed drugs.
Level 2/517 Flinders Ln, Melbourne VIC 3000, Australia
Fresh Equities does not have PARADIGM BIOPHARMACEUTICALS LIMITED directors data.